News
Libtayo approved by EC as immunotherapy for cervical cancer
The European Commission (EC) has approved Regeneron Pharmaceuticals' Libtayo (cemiplimab) as monotherapy for the treatment of adult patients with recurrent or metastatic cervical cancer...
European Commission approves AbbVie’s SKYRIZI to treat moderate to severe active Crohn’s Disease
The European Commission (EC) has approved AbbVie's SKYRIZI (risankizumab, 600 mg intravenous induction and 360 mg subcutaneous maintenance therapy) as the first...
FDA approves first gene therapy to treat adults with Hemophilia B
The U.S. Food and Drug Administration has approved Hemgenix (etranacogene dezaparvovec), an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia...
